339982 RESULTS
SERIES Move over, genome, transcriptome, proteome. The latest ome aims to map every metabolite linked to human health and disease. Metabolomics, although still a nascent field, offers hope for biomarkers and treatments in neurodegenerative disease. The field
RESEARCH NEWS 2011-03-01 Research News Metabolomics—the sum of every small molecule linked to health or illness—is a young field (see Part 1 and Part 2), but it has already given researchers studying Alzheimer’s disease plenty to think about (see Part 3). Scientists studying othe
RESEARCH NEWS 2011-03-01 Research News Scientists’ view of amyloid’s role in Alzheimer’s disease has evolved from the view that large amyloid fibrils poison the brain to one primarily blaming soluble, oligomeric forms of Aβ. A similar evolution of thought may be on the horizon fo
RESEARCH NEWS 2011-03-01 Research News For creatures ranging from yeast to worms to mice, impaired growth hormone signaling restricts size but brings big benefits—longer life, and protection from age-related disease. Now, a 22-year longitudinal study confirms that some of these a
PAPER Armon C
PAPER Alonso A, Logroscino G, Jick SS, Hernán MA
PAPER Alonso A, Logroscino G, Hernán MA
PAPER Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, Sakamoto N, Inaba Y, Nagai M
PAPER Gallo V, Bueno-de-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, Kaaks R, Allen NE, Roddam AW, Boshuizen HC, Peeters PH, Palli D, Mattiello A, Sieri S, Tumino R, Jiménez-Martín JM, Díaz MJ, Suarez LR, Trichopoulou A, Agudo A, Arriola L, Barricante-Gurrea A, Bingham S, Khaw KT, Manjer J, Lindkvist B, Overvad K, Bach FW, Tjønneland A, Olsen A, Bergmann MM, Boeing H, Clavel-Chapelon F, Lund E, Hallmans G, Middleton L, Vineis P, Riboli E
PAPER Binazzi A, Belli S, Uccelli R, Desiato MT, Talamanca IF, Antonini G, Corsi FM, Scoppetta C, Inghilleri M, Pontieri FE, Vanacore N,
PAPER Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP
PAPER Wang H, O'Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, Schatzkin A, Kolonel LN, Ascherio A
RESEARCH NEWS 2011-02-28 Research News Metabolomics holds the promise of giant metabolite screens, leading to a bounty of clues to Alzheimer’s disease (see Part 1). Alzheimer’s researchers are certainly familiar with big science; the Alzheimer’s Disease Neuroimaging Initiative (A
RESEARCH NEWS 2011-02-28 Research News As if there wasn’t already enough reasons not to light up, a new study in the February Archives of Neurology reports that smoking boosts one’s risk of amyotrophic lateral sclerosis (ALS) by a factor of 1.4. The study, led by Hao Wang at the
PAPER Niebroj-Dobosz I, Janik P
